BioWorld

June 11, 2004

View Archived Issues

Isolagen Offering Raises $59.5M For Autologous Cellular Therapies

Tissue-regeneration company Isolagen Inc. brought in $59.5 million in a follow-on offering Thursday, leaving it with wrinkle-free plans to begin pivotal trials and bring its lead anti-aging product to the market. (BioWorld Today) Read More

BioNumerik Files For IPO To Fund Late-Stage Cancer Drugs

Read More

Cancer Researchers Continue Radioimmunotherapy Exploration

Read More

Peninsula Begins Phase III Trial Of Doripenem For Pneumonia

Read More

Correction

Read More

Other News To Note

Read More